Share Price:

APNASPENAspen Pharmacare Hldgs2195232 (0.15%)

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform to be released on 4 March 2024.

Former President Clinton Announces New Agreements to Lower Prices of HIV/AIDS Rapid Tests and Second-Line Drugs

Former President Clinton Announces New Agreements to Lower Prices of HIV/AIDS Rapid Tests and Second-Line Drugs Agreements with Nine Companies Will Lower Prices of HIV Diagnosis and Two HIV/AIDS Medicines by 30-50 Percent for 50 Countries Clinton Also Confirms that Nearly a Quarter-Million People Living with HIV are Benefiting from First-Line HIV/AIDS Drug Agreements his… Continue reading Former President Clinton Announces New Agreements to Lower Prices of HIV/AIDS Rapid Tests and Second-Line Drugs

Aspen Opens R1 million Wellness Centre

JSE listed Aspen Pharmacare, Africa’s largest pharmaceutical manufacturer and the leading global player in generic anti-retrovirals (ARVs), earlier today opened a R1 million wellness centre in the Eastern Cape.   Through a public-private partnership, Aspen’s investment in the establishment of the Wells Estate Wellness Centre will enhance the primary healthcare services at the Nelson Mandela… Continue reading Aspen Opens R1 million Wellness Centre

Aspen and Lupin sign TB deal

JSE listed Aspen Pharmacare Holdings Limited and Lupin Limited of India have entered into an agreement to collaborate in the tuberculosis (TB) related products market in South Africa. The agreement involves cooperation in the areas of technology, manufacture and marketing. Stephen Saad, Aspen Group Chief Executive said, “the agreement enhances South Africa and Aspen’s ability… Continue reading Aspen and Lupin sign TB deal

Aspen and India’s Matrix sign JVs

Aspen Pharmacare Holdings Limited (Aspen) has signed definitive joint venture (JV) agreements with Indian-based Matrix Laboratories Limited (Matrix). The deals strengthen Aspen’s vertical integration into the manufacture of Active Pharmaceutical Ingredients (APIs), the key raw materials required in the manufacture of finished dosage form pharmaceuticals including anti-retrovirals (ARVs), and they unlock additional global supply and… Continue reading Aspen and India’s Matrix sign JVs

Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.